SMO and medulloblastoma: Furthermore, we show that that pharmacological inhibition of HDAC activity during early postnatal development of the cerebellum could block Shh-induced CGP hyperplasia in the Smo/Smo mice suggesting that HDAC inhibitors may be especially beneficial early on or in very young children for therapeutic intervention in medulloblastoma.